Parsec Financial Management, Inc. Eli Lilly & CO Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

A detailed history of Parsec Financial Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 72,956 shares of LLY stock, worth $65.9 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

72,956

Previous 76,972 5.22%

Holding current value

$65.9 Million

Previous $28.2 Million 11.03%

% of portfolio

1.06%

Previous 1.26%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $1.25 Million - $1.47 Million	-4,016 Reduced 5.22%	72,956 $25.1 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $1.1 Million - $1.28 Million	-3,406 Reduced 4.24%	76,972 $28.2 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $1.88 Million - $2.14 Million	-6,335 Reduced 7.31%	80,378 $26 Million
Q2 2022 Jul 06, 2022	SELL	$278.73 - $327.27 $1.32 Million - $1.55 Million	-4,725 Reduced 5.17%	86,713 $28.1 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $253,230 - $314,701	-1,079 Reduced 1.17%	91,438 $26.2 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $168,862 - $209,559	-751 Reduced 0.81%	92,517 $25.6 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $575,273 - $707,955	2,596 Added 2.86%	93,268 $24.4 Million
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $196,077 - $253,624	1,086 Added 1.21%	90,672 $20.8 Million
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $564,767 - $731,118	3,437 Added 3.99%	89,586 $16.7 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $330,585 - $437,444	2,534 Added 3.03%	86,149 $14.5 Million
Q3 2020 Nov 06, 2020	BUY	$146.22 - $169.13 $69,746 - $80,675	477 Added 0.57%	83,615 $12.4 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $493,021 - $593,346	-3,614 Reduced 4.17%	83,138 $13.7 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $120,240 - $148,823	1,010 Added 1.18%	86,752 $12 Million
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $41,271 - $51,117	386 Added 0.45%	85,742 $11.3 Million
Q3 2019 Oct 23, 2019	SELL	$106.79 - $116.16 $362,338 - $394,130	-3,393 Reduced 3.82%	85,356 $9.55 Million
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $126,632 - $147,812	-1,143 Reduced 1.27%	88,749 $0
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $219,948 - $258,895	-1,976 Reduced 2.15%	89,892 $11.7 Million
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $179,076 - $200,620	-1,691 Reduced 1.81%	91,868 $10.6 Million
Q3 2018 Oct 30, 2018	BUY	$85.86 - $107.31 $364,905 - $456,067	4,250 Added 4.76%	93,559 $10 Million
Q2 2018 Jul 26, 2018	BUY	$75.7 - $86.88 $335,351 - $384,878	4,430 Added 5.22%	89,309 $7.62 Million
Q1 2018 Apr 25, 2018	BUY	$74.21 - $87.6 $453,942 - $535,849	6,117 Added 7.77%	84,879 $6.57 Million
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $1.64 Million - $1.76 Million	20,000 Added 34.04%	78,762 $6.65 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $4.53 Million - $5.03 Million	58,762	58,762 $5.03 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account

Parsec Financial Management, Inc. Eli Lilly & CO Transaction History